Geoffroy Goujon

Geoffroy Goujon studied in Paris and has general neuroscience biology background.
He obtained his master’s degree in biology in 2016. During the first year of his master’s he worked on iPS cells as a new model for studying amyotrophic lateral sclerosis (Brain and Spinal Cord Institute, Paris) . Then he worked on the impact of varenicline on early hyperactivity related to Alzheimer’s disease (Pasteur Institute, Paris).
He completed his PhD of Pharmacology at Paris Descartes University in 2019 where he worked on the therapeutic potential of innovative cerium oxide nanoparticles for cerebral ischemia.

Find more information on my LinkedIn profile.